928 results on '"Ilan, Yaron"'
Search Results
52. Department of Medicine 2040: Implementing a Constrained Disorder Principle-Based Second-Generation Artificial Intelligence System for Improved Patient Outcomes in the Department of Internal Medicine
53. Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms
54. A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection
55. Enhancing the plasticity, proper function and efficient use of energy of the Sun, genes and microtubules using variability
56. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance
57. Abstract PO001: Preclinical activity of glypican-3 (GPC3) and NKp46 directed FLEX-NK™ engager antibody (CYT-303) in combination with iPSC derived natural killer cells (iNKs) or peripheral blood (PB) NK cells in hepatocellular carcinoma (HCC)
58. Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases
59. Reduced liver cell death using an alginate scaffold bandage: A novel approach for liver reconstruction after extended partial hepatectomy
60. Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial.
61. Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function
62. Oral tolerance for treatment of GI inflammation
63. Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects
64. Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?
65. Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
66. A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review
67. Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis
68. Manifestations of Inherited Disorders of Bilirubin Glucuronidation During Infancy and Childhood
69. Bilirubin Metabolism and Hyperbilirubinemia
70. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
71. Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
72. The role of bacterial translocation in sepsis: a new target for therapy
73. Personalized-Inherent Variability in a Time-Dependent Immune Response: A Look into the Fifth Dimension in Biology
74. Improving the long-term response to antidepressants by establishing an individualized platform based on variability and chronotherapy
75. Correlations between components of the immune system
76. Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report
77. Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors
78. Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID‐19
79. Immune therapy for hepatocellular carcinoma
80. Role of circadian rhythm and autonomic nervous system in liver function: a hypothetical basis for improving the management of hepatic encephalopathy
81. Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/ IIa clinical trial: A method for the prevention and treatment of COVID ‐19
82. Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm
83. Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?
84. Decreased STAT-1 phosphorylation by a thio analogue of beta-d-glucosylceramide is associated with altered NKT lymphocyte polarization
85. Establishment of an Individualized Chronotherapy, Autonomic Nervous System, and Variability-Based Dynamic Platform for Overcoming the Loss of Response to Analgesics
86. β-Glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: A novel adjuvant for HBV vaccination
87. Modulation of intracellular machinery by β-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis
88. Evaluation of the 13C-Octanoate Breath Test as a Surrogate Marker of Liver Damage in Animal Models
89. Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells
90. [beta]-Glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat
91. Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID‐19.
92. Viral Diseases of the Liver
93. Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor
94. The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways
95. Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach
96. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes
97. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes
98. The 13 C‐methactin breath test is non‐inferior to liver biopsy in predicting liver‐related death and transplantation: A 7‐year prospective follow‐up study in 132 patients with chronic hepatitis C infection
99. Impaired liver regeneration by β-glucosylceramide is associated with decreased fat accumulation
100. Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.